2003Yanke xinjinzhanRequires access

Application of mitomycin C in laser lacryocystoplasty

LV Hong, Qiang Lü

Open publisher page 0 citations

Abstract

ObjectiveTo evaluate the effects of mitomycin C(MMC) in laser lacryocystoplasty.MethodsSixty patients(71 eyes) with obstruction of lacrimal passage were randomly divided into MMC group and control group.In MMC group, 29 cases (35 eyes) firstly applied 0.25g·L -1 MMC for 5 minutes and then filled up TobraDex ointment. In control group, 31 cases (36 eyes) didn't apply MMC. All patients were followed up for 3~15 months. ResultsThe success rate of operation was 88.6% in MMC group and 69 4% in control group (P0.05).ConclusionMMC (0 25g·L -1) can effectively inhibit the scar formation, thus providing a higher successful rate of laser lacryocystoplasty.

About this research paper

What this paper is about

ObjectiveTo evaluate the effects of mitomycin C(MMC) in laser lacryocystoplasty.MethodsSixty patients(71 eyes) with obstruction of lacrimal passage were randomly divided into MMC group and control group.In MMC group, 29 cases (35 eyes) firstly applied 0.25g·L -1 MMC for 5 minutes and then filled up TobraDex ointment. In control group, 31 cases (36 eyes) didn't apply MMC. All patients were followed up for 3~15 months. ResultsThe success rate of operation was 88.6% in MMC group and 69 4% in control group (P0.05).ConclusionMMC (0 25g·L -1) can effectively inhibit the scar formation, thus providing a higher successful rate of laser lacryocystoplasty.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ObjectiveTo evaluate the effects of mitomycin C(MMC) in laser lacryocystoplasty.MethodsSixty patients(71 eyes) with obstruction of lacrimal passage were randomly divided into MMC group and control group.In MMC group, 29 cases (35 eyes) firstly applied 0.25g·L -1 MMC for 5 minutes and then filled up TobraDex ointment. In control group, 31 cases (36 eyes) didn't apply MMC. All patients were followed up for 3~15 months. ResultsThe success rate of operation was 88.6% in MMC group and 69 4% in control group (P0.05).ConclusionMMC (0 25g·L -1) can effectively inhibit the scar formation, thus providing a higher successful rate of laser lacryocystoplasty.

Key concepts: Mitomycin C, Surgery, Medicine, Laser, Ophthalmology, Optics, Physics

Related papers

Back to paper searchBrowse research topicsOriginal source
Application of mitomycin C in laser lacryocystoplasty — Research Paper | ScholarLens